Drug Class: DPP-4 Inhibitor (Dipeptidyl Peptidase-4 Inhibitor) / Gliptin | Form: Oral Tablet | Prescription Status: Prescription Only (Rx) — DRAP Registered
What is Tagip 100mg Tablet? Tagip 100mg contains Sitagliptin Phosphate Monohydrate — a DPP-4 inhibitor that improves blood sugar control in Type 2 diabetes through a glucose-dependent mechanism that naturally reduces the risk of hypoglycaemia compared to older antidiabetic medicines. By blocking the DPP-4 enzyme that normally breaks down incretin hormones, Sitagliptin allows these natural glucose-regulating hormones to remain active longer — stimulating insulin release and suppressing glucagon only when blood sugar is actually elevated. This smart glucose-dependent action means Sitagliptin works harder when blood sugar is high and automatically reduces its effect as glucose normalises — significantly lowering the dangerous low blood sugar risk associated with sulphonylureas. It is used as monotherapy or in combination with Metformin, sulphonylureas, or insulin under medical supervision.
What is Tagip 100mg Used For?
- Type 2 diabetes mellitus — improving glycaemic control as monotherapy when diet and exercise alone are insufficient (ذیابیطس ٹائپ 2 میں بلڈ شوگر کنٹرول)
- Combination therapy with Metformin — when Metformin alone provides inadequate blood sugar control
- Combination therapy with sulphonylurea — when dual therapy is needed under medical supervision
- Combination with insulin — improving glycaemic control in patients on insulin therapy
- Type 2 diabetes in patients where hypoglycaemia risk must be minimised — elderly patients and those with irregular meal schedules
How Does it Work? Sitagliptin selectively and reversibly inhibits DPP-4 enzyme — the enzyme that normally rapidly degrades GLP-1 and GIP incretin hormones within minutes of their release after meals. By blocking DPP-4, Sitagliptin increases active incretin levels two to three-fold — allowing these natural hormones to exert their full glucose-lowering effects. Elevated active GLP-1 stimulates pancreatic beta cells to release insulin in response to elevated blood glucose and simultaneously suppresses glucagon secretion from alpha cells — reducing hepatic glucose output. Both these actions are strictly glucose-dependent — meaning they only occur when blood sugar is actually elevated, producing effective postprandial glucose control without causing dangerous hypoglycaemia during normal or low blood sugar states.
Dosage and Administration
⚠️ Monitor kidney function regularly — dose reduction to 50mg is required in moderate kidney impairment and 25mg in severe impairment. Never stop without doctor advice. Monitor for signs of pancreatitis — severe persistent abdominal pain requires immediate medical attention. Can be taken with or without food.
| Indication | Usual Adult Dose | Frequency | Notes |
|---|---|---|---|
| Type 2 diabetes — monotherapy | 100mg | Once daily | With or without food |
| Combination with Metformin | 100mg | Once daily | Alongside Metformin dose |
| Combination with sulphonylurea | 100mg | Once daily | Sulphonylurea dose may need reduction |
| Combination with insulin | 100mg | Once daily | Insulin dose adjustment may be needed |
| Moderate kidney impairment | 50mg | Once daily | GFR 30 to 50ml/min |
| Severe kidney impairment | 25mg | Once daily | GFR below 30ml/min |
Active Ingredients
| Ingredient | Strength |
|---|---|
| Sitagliptin Phosphate Monohydrate | 100mg (as Sitagliptin) |
Who Should NOT Take Tagip 100mg?
- Allergy to Sitagliptin or any DPP-4 inhibitor
- Type 1 diabetes mellitus — Tagip is not indicated for Type 1 diabetes
- Diabetic ketoacidosis — requires insulin therapy not oral antidiabetics
- History of pancreatitis — Sitagliptin associated with increased pancreatitis risk
- Severe kidney failure requiring dialysis — use 25mg with specialist guidance only
- Pregnancy and breastfeeding — insulin remains the preferred treatment during pregnancy
- Children under 18 years — safety not established
Side Effects
Common: Mild upper respiratory tract infection symptoms — runny nose and sore throat (ناک بہنا اور گلے کا درد), mild headache, mild nausea, mild diarrhoea — generally very well tolerated with a low side effect burden compared to older antidiabetic medicines.
Serious — Stop and seek emergency help immediately: Acute pancreatitis — severe persistent upper abdominal pain radiating to the back with nausea and vomiting (پیٹ میں شدید درد — فوری ہسپتال جائیں), severe allergic reaction — sudden widespread rash, swelling of face or throat, difficulty breathing (فوری ہسپتال جائیں), severe skin reactions — Stevens-Johnson syndrome with widespread blistering (فوری مدد لیں), significant joint pain — arthralgia that may be severe and disabling (جوڑوں کا شدید درد — ڈاکٹر کو بتائیں), heart failure worsening — sudden breathlessness with ankle swelling in patients with established cardiac disease (فوری مدد لیں), hypoglycaemia — particularly when combined with sulphonylurea or insulin (بلڈ شوگر کا گرنا — میٹھا کھائیں).
Drug Interactions
| Medicine | Interaction |
|---|---|
| Sulphonylureas (Glibenclamide, Glimepiride) | Increased hypoglycaemia risk — sulphonylurea dose reduction typically required when adding Sitagliptin |
| Insulin | Increased hypoglycaemia risk — insulin dose adjustment required under doctor supervision |
| Digoxin | Sitagliptin slightly increases Digoxin blood levels — monitor Digoxin levels in patients on both |
| Cyclosporine | Increases Sitagliptin blood levels — monitor for increased side effects |
| Metformin | No clinically significant interaction — commonly prescribed together as complementary antidiabetics |
| Corticosteroids (Prednisolone) | Raise blood glucose — may reduce Sitagliptin effectiveness; monitor blood sugar closely |
| Beta-blockers (Atenolol, Metoprolol) | Mask hypoglycaemia warning signs — important caution when Sitagliptin combined with sulphonylurea or insulin |
| Alcohol (شراب) | Unpredictable blood sugar effects — avoid excessive consumption during antidiabetic treatment |
Storage: Store below 25°C in a cool, dry place. Protect from moisture and direct sunlight. Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں). Do not use after expiry date.
FAQs
Q: Does Tagip 100mg cause low blood sugar on its own? Sitagliptin has a very low hypoglycaemia risk when used alone or with Metformin — its glucose-dependent mechanism means it only stimulates insulin release when blood sugar is actually elevated. Hypoglycaemia risk increases meaningfully when combined with sulphonylureas or insulin — dose adjustment of those medicines is typically required.
Q: Why must kidney function be checked regularly while taking Tagip 100mg? Sitagliptin is primarily excreted through the kidneys — reduced kidney function causes drug accumulation and increased side effect risk. Regular kidney function monitoring allows your doctor to adjust the dose appropriately — reducing to 50mg or 25mg as kidney function declines to maintain safety throughout long-term treatment.
Q: Can Tagip 100mg be used in elderly Type 2 diabetic patients? Yes — Sitagliptin is particularly well suited to elderly patients due to its low hypoglycaemia risk, once-daily dosing convenience, and good tolerability. However kidney function must be assessed before and regularly during treatment in elderly patients as age-related kidney decline may require dose reduction.
Medical Disclaimer: This information is for general awareness only and does not replace medical advice. Always consult a qualified doctor or pharmacist before taking any prescription medicine.